Karyopharm Therapeutics
KPTI
#11298
Rank
$0.39 M
Marketcap
$0.01740
Share price
0.00%
Change (1 day)
-99.68%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2013

Volume in USD (price x number of shares), data since 2013

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$1.16 M-97.87%
2023$54.81 M18.97%
2022$46.07 M5.78%
2021$43.55 M77.73%
2020$24.5 M33.34%
2019$18.38 M106.04%
2018$8.92 M-65.24%
2017$25.66 M334.29%
2016$5.9 M-84.55%
2015$38.24 M-42.24%
2014$66.21 M11206.31%
2013$0.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
$9.78 M$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$39.18 M$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$17.12 M$92.07 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$6.2 M$30.62 M๐Ÿ‡บ๐Ÿ‡ธ USA